^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Esophageal Cancer |
| Regimen: | IP (cisplatin + irinotecan) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Esophageal and Esophagogastric Junction Cancers: Other Recommended Regimens…Irinotecan and cisplatin.
